Bio-Pharma Market Report

China Bio-Pharma Industry Market Research Report 2023-2029

  • POSTDATE：Oct 03, 2023
  • PAGES：196
  • REPORT CODE：GMM1822423
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Bio-Pharma industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Bayer AG

    • Eli Lilly and Company

    • AstraZeneca PLC

    • Johnson & Johnson Services

    • F Hoffmann-La Roche AG

    • Sanofi, Amgen

    • Merck & Co, Inc

    • Abbott Laboratories

    • Biogen Idec

    • AbbVie

    By Type:

    • Recombinant Human Insulin

    • Growth Hormones

    • Erythropoietin

    • Monoclonal Antibodies

    • Granulocyte-Colony Stimulating Factor (G-CSF)

    • Interferons

    • Recombinant Proteins

    • Vaccines

    • Purified Proteins

    • Others

    By Application:

    • Metabolic Disorders

    • Cardiovascular Diseases

    • Others

    • Neurological Disorders

    • Inflammatory and Infectious Diseases

    • Oncology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bio-Pharma Market Overview 2018-2029

    • 1.1 China Bio-Pharma Industry Development Overview

    • 1.2 China Bio-Pharma Industry Development History

    • 1.3 China Bio-Pharma Industry Market Size (2018-2029)

    • 1.4 China Bio-Pharma Market Analysis by Type from Production Side

      • 1.4.1 China Bio-Pharma Production Volume, Production Value and Growth Rate of Recombinant Human Insulin (2018-2029)

      • 1.4.2 China Bio-Pharma Production Volume, Production Value and Growth Rate of Growth Hormones (2018-2029)

      • 1.4.3 China Bio-Pharma Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)

      • 1.4.4 China Bio-Pharma Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

      • 1.4.5 China Bio-Pharma Production Volume, Production Value and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2018-2029)

      • 1.4.6 China Bio-Pharma Production Volume, Production Value and Growth Rate of Interferons (2018-2029)

      • 1.4.7 China Bio-Pharma Production Volume, Production Value and Growth Rate of Recombinant Proteins (2018-2029)

      • 1.4.8 China Bio-Pharma Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

      • 1.4.9 China Bio-Pharma Production Volume, Production Value and Growth Rate of Purified Proteins (2018-2029)

      • 1.4.10 China Bio-Pharma Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Bio-Pharma Market Analysis by Application from Consumption End

      • 1.5.1 China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)

      • 1.5.2 China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Cardiovascular Diseases (2018-2029)

      • 1.5.3 China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Neurological Disorders (2018-2029)

      • 1.5.5 China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Inflammatory and Infectious Diseases (2018-2029)

      • 1.5.6 China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • 1.6 China Bio-Pharma Market Analysis by Region

      • 1.6.1 North China Bio-Pharma Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bio-Pharma Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bio-Pharma Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bio-Pharma Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bio-Pharma Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bio-Pharma Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bio-Pharma Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bio-Pharma Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bio-Pharma Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bio-Pharma Market Status and Competition Analysis in 2023

      • 2.2.3 China Bio-Pharma Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bio-Pharma Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bio-Pharma Industry Development

    Chapter 3 Bio-PharmaIndustry Chain Analysis

    • 3.1 Bio-Pharma Industry Chain

    • 3.2 Bio-Pharma Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bio-Pharma Market

    • 3.3 Bio-Pharma Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bio-Pharma Market

    Chapter 4 China Bio-Pharma Market, by Type

    • 4.1 China Bio-Pharma Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bio-Pharma Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bio-Pharma Production Volume and Growth Rate, by Type

      • 4.5.1 China Bio-Pharma Production Volume and Growth Rate of Recombinant Human Insulin

      • 4.5.2 China Bio-Pharma Production Volume and Growth Rate of Growth Hormones

      • 4.5.3 China Bio-Pharma Production Volume and Growth Rate of Erythropoietin

      • 4.5.4 China Bio-Pharma Production Volume and Growth Rate of Monoclonal Antibodies

      • 4.5.5 China Bio-Pharma Production Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF)

      • 4.5.6 China Bio-Pharma Production Volume and Growth Rate of Interferons

      • 4.5.7 China Bio-Pharma Production Volume and Growth Rate of Recombinant Proteins

      • 4.5.8 China Bio-Pharma Production Volume and Growth Rate of Vaccines

      • 4.5.9 China Bio-Pharma Production Volume and Growth Rate of Purified Proteins

      • 4.5.10 China Bio-Pharma Production Volume and Growth Rate of Others

    Chapter 5 China Bio-Pharma Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bio-Pharma Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bio-Pharma Market Size and Growth Rate, by Application

      • 5.5.1 China Bio-Pharma Market Size and Growth Rate of Metabolic Disorders

      • 5.5.2 China Bio-Pharma Market Size and Growth Rate of Cardiovascular Diseases

      • 5.5.3 China Bio-Pharma Market Size and Growth Rate of Others

      • 5.5.4 China Bio-Pharma Market Size and Growth Rate of Neurological Disorders

      • 5.5.5 China Bio-Pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases

      • 5.5.6 China Bio-Pharma Market Size and Growth Rate of Oncology

    Chapter 6 China Bio-Pharma Market, by Region

    • 6.1 China Bio-Pharma Production Volume and Production Value, by Region

    • 6.2 China Bio-Pharma Sales Volume and Sales Value, by Region

    Chapter 7 North China Bio-Pharma Market Analysis

    • 7.1 North China Bio-Pharma Market, by Type

    • 7.2 North China Bio-Pharma Market, by Application

    Chapter 8 Central China Bio-Pharma Market Analysis

    • 8.1 Central China Bio-Pharma Market, by Type

    • 8.2 Central China Bio-Pharma Market, by Application

    Chapter 9 South China Bio-Pharma Market Analysis

    • 9.1 South China Bio-Pharma Market, by Type

    • 9.2 South China Bio-Pharma Market, by Application

    Chapter 10 East China Bio-Pharma Market Analysis

    • 10.1 East China Bio-Pharma Market, by Type

    • 10.2 East China Bio-Pharma Market, by Application

    Chapter 11 Northeast China Bio-Pharma Market Analysis

    • 11.1 Northeast China Bio-Pharma Market, by Type

    • 11.2 Northeast China Bio-Pharma Market, by Application

    Chapter 12 Southwest China Bio-Pharma Market Analysis

    • 12.1 Southwest China Bio-Pharma Market, by Type

    • 12.2 Southwest China Bio-Pharma Market, by Application

    Chapter 13 Northwest China Bio-Pharma Market Analysis

    • 13.1 Northwest China Bio-Pharma Market, by Type

    • 13.2 Northwest China Bio-Pharma Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Bio-Pharma Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Bayer AG

        • 14.2.1 Bayer AG Company Profile

        • 14.2.2 Bayer AG Bio-Pharma Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eli Lilly and Company

        • 14.3.1 Eli Lilly and Company Company Profile

        • 14.3.2 Eli Lilly and Company Bio-Pharma Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AstraZeneca PLC

        • 14.4.1 AstraZeneca PLC Company Profile

        • 14.4.2 AstraZeneca PLC Bio-Pharma Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Johnson & Johnson Services

        • 14.5.1 Johnson & Johnson Services Company Profile

        • 14.5.2 Johnson & Johnson Services Bio-Pharma Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 F Hoffmann-La Roche AG

        • 14.6.1 F Hoffmann-La Roche AG Company Profile

        • 14.6.2 F Hoffmann-La Roche AG Bio-Pharma Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Sanofi, Amgen

        • 14.7.1 Sanofi, Amgen Company Profile

        • 14.7.2 Sanofi, Amgen Bio-Pharma Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck & Co, Inc

        • 14.8.1 Merck & Co, Inc Company Profile

        • 14.8.2 Merck & Co, Inc Bio-Pharma Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbott Laboratories

        • 14.9.1 Abbott Laboratories Company Profile

        • 14.9.2 Abbott Laboratories Bio-Pharma Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Biogen Idec

        • 14.10.1 Biogen Idec Company Profile

        • 14.10.2 Biogen Idec Bio-Pharma Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AbbVie

        • 14.11.1 AbbVie Company Profile

        • 14.11.2 AbbVie Bio-Pharma Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bio-Pharma Industry Research Conclusions

    • 15.2 Bio-Pharma Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bio-Pharma Industry Market Size (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Recombinant Human Insulin (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Growth Hormones (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Erythropoietin (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Interferons (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Recombinant Proteins (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Purified Proteins (2018-2029)

    • Figure China Bio-Pharma Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Metabolic Disorders (2018-2029)

    • Figure China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Cardiovascular Diseases (2018-2029)

    • Figure China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Neurological Disorders (2018-2029)

    • Figure China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Inflammatory and Infectious Diseases (2018-2029)

    • Figure China Bio-Pharma Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure North China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure Central China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure South China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure East China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bio-Pharma Market Size and Growth Rate from 2018-2029

    • Figure Bio-Pharma Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bio-Pharma Market Share by Type in 2018

    • Figure China Bio-Pharma Market Share by Type in 2023

    • Figure China Bio-Pharma Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Recombinant Human Insulin (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Growth Hormones (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Erythropoietin (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Granulocyte-Colony Stimulating Factor (G-CSF) (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Interferons (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Recombinant Proteins (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Vaccines (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Purified Proteins (2018-2023)

    • Figure China Bio-Pharma Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Bio-Pharma Market Share by Application in 2018

    • Figure China Bio-Pharma Market Share by Application in 2023

    • Figure China Bio-Pharma Total Market Size and Growth Rate from Consumption End

    • Figure China Bio-Pharma Market Size and Growth Rate of Metabolic Disorders (2018-2023)

    • Figure China Bio-Pharma Market Size and Growth Rate of Cardiovascular Diseases (2018-2023)

    • Figure China Bio-Pharma Market Size and Growth Rate of Others (2018-2023)

    • Figure China Bio-Pharma Market Size and Growth Rate of Neurological Disorders (2018-2023)

    • Figure China Bio-Pharma Market Size and Growth Rate of Inflammatory and Infectious Diseases (2018-2023)

    • Figure China Bio-Pharma Market Size and Growth Rate of Oncology (2018-2023)

    • Table China Bio-Pharma Production Volume by Region (2018-2023)

    • Table China Bio-Pharma Production Volume Share by Region (2018-2023)

    • Figure China Bio-Pharma Production Volume Share by Region (2018-2023)

    • Table China Bio-Pharma Production Value by Region (2018-2023)

    • Table China Bio-Pharma Production Value Share by Region (2018-2023)

    • Figure China Bio-Pharma Production Value Share by Region (2018-2023)

    • Table China Bio-Pharma Sales Volume by Region (2018-2023)

    • Table China Bio-Pharma Sales Volume Share by Region (2018-2023)

    • Figure China Bio-Pharma Sales Volume Share by Region (2018-2023)

    • Table China Bio-Pharma Sales Value by Region (2018-2023)

    • Table China Bio-Pharma Sales Value Share by Region (2018-2023)

    • Figure China Bio-Pharma Sales Value Share by Region (2018-2023)

    • Table North China Bio-Pharma Production Volume by Type (2018-2023)

    • Table North China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure North China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table North China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table North China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure North China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table Central China Bio-Pharma Production Volume by Type (2018-2023)

    • Table Central China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure Central China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table Central China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table Central China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure Central China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table South China Bio-Pharma Production Volume by Type (2018-2023)

    • Table South China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure South China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table South China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table South China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure South China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table East China Bio-Pharma Production Volume by Type (2018-2023)

    • Table East China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure East China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table East China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table East China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure East China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bio-Pharma Production Volume by Type (2018-2023)

    • Table Northeast China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table Northeast China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table Northeast China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bio-Pharma Production Volume by Type (2018-2023)

    • Table Southwest China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table Southwest China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table Southwest China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bio-Pharma Production Volume by Type (2018-2023)

    • Table Northwest China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bio-Pharma Production Volume Share by Type (2018-2023)

    • Table Northwest China Bio-Pharma Sales Volume by Application (2018-2023)

    • Table Northwest China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bio-Pharma Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Bayer AG Company Profile

    • Table Bayer AG Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca PLC Company Profile

    • Table AstraZeneca PLC Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Services Company Profile

    • Table Johnson & Johnson Services Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Sanofi, Amgen Company Profile

    • Table Sanofi, Amgen Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec Company Profile

    • Table Biogen Idec Bio-Pharma Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Bio-Pharma Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US